Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

   * Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Ethex

Ethex Side Effects May Lead To High Blood Pressure Lawsuits

Ethex | Lawsuits, Lawyers | Side Effects: Irregular Heartbeat, Rapid Heart Rate, High Blood Pressure, Low Blood Pressure

In November 2008, ETHEX Corporation recalled various lots and sizes of Propafenone HCl Tablets, Isosorbide Mononitrate Extended Release Tablets, Morphine Sulfate Extended Release Tablets, Morphine Sulfate Immediate Release Tablets and Dextroamphetamine Sulfate Tablets. ETHEX initiated the recall because of the potential that some of the tablets were oversize. Oversize tablets may contain more than the intended levels of the active drug ingredient, which could result in an overdose.

According to the Food and Drug Administration (FDA) overdoses of Propafenone HCl, Isosorbide Mononitrate, Morphine sulfate and Dextroamphetamine Sulfate can have serious or life-threatening consequences. Excessive exposure to Propafenone HCl can cause arrhythmias (irregular heartbeat) and low blood pressure. In the case of Isosorbide Mononitrate, these consequences can include fainting and low blood pressure. The consequences of Morphine Sulfate overdose can include respiratory depression (difficulty or lack of breathing) and low blood pressure. An overdose of Dextroamphetamine Sulfate can caused rapid heart rate and high blood pressure.

If you or someone you know experienced an overdose because of defective Propafenone HCl Tablets, Isosorbide Mononitrate Extended Release Tablets, Morphine Sulfate Extended Release Tablets Morphine Sulfate Immediate Release Tablets and Dextroamphetamine Sulfate Tablets recalled by ETHEX Corporation, you may be entitled to compensation. Please contact one of our ETHEX generic drug recall lawyers right away to protect your legal rights.

Medications Included in ETHEX Generic Drug Recall

According to the FDA, the November 2008 ETHEX recall included the following generic medications: Propafenone HCl Tablets, 150 mg: The 150 mg Propafenone Hydrochloride Tablets is a white, scored round film coated tablet with ETH on one side and 331 with a bisect on the reverse. Lots: 73761, 78184, 79373, 81240, 81241, 81242, 83470, 84357, 90525, and 90526 with expiration dates ranging from 3/2009 to 3/2011

Propafenone HCl Tablets, 225 mg: The 225 mg Propafenone Hydrochloride Tablets is a white, scored round film coated tablet with ETH on one side and 332 with a bisect on the reverse. Lots: 71720, 74831, 76014-15, 81243-45, 89731, 90527-29, and 90657 with expiration dates ranging from 3/2009 to 2/2011

Propafenone HCl Tablets, 300 mg: The 300 mg Propafenone Hydrochloride Tablets is a white, scored round film coated tablet with ETH on one side and 333 with a bisect on the reverse. Lots: 72834, 76016-18, 81246, 89092, 89732, 90530, 90532, and 91641-42 with expiration dates ranging from 6/2009 to 3/2011

Isosorbide Mononitrate Extended Release Tablets, 30 mg: The 30 mg Isosorbide Mononitrate Extended Release Tablet is an oval, reddish-pink, film-coated tablet with a debossed "E" bisecting "30" on one side and bisect on the other side. Lots: 62355, 66423, and 68102 with expiration dates ranging from 11/2008 to 8/2009

Isosorbide Mononitrate Extended Release Tablets, 60 mg: The 60 mg Isosorbide Mononitrate Extended Release Tablet is an oval, yellow film-coated tablet with a debossed E bisect 60 on one side and bisect on the other side. Lots: 63466, 66034, 67351, and 67354 with expiration dates ranging from 12/2008 to 11/2009

Morphine Sulfate Extended Release Tablets, 15 mg: The 15 mg Morphine Sulfate Extended Release Tablet is a green oval tablet with "15" on one side and an "E" on the reverse. Lots: 81175, 82514-16, 89660, 89664, 89667, 90249-51, and 91687 with expiration dates ranging from 12/2008 to 2/2010

Morphine Sulfate Immediate Release Tablets, 15 mg: The 15 mg Morphine Sulfate Immediate Release Tablet is a round brown tablet with a "15" on one side and an ETH on the reverse. Lots: 77852-54, 81746, 82519-20, 84113, and 90276-78 with expiration dates ranging from 9/2009 to 1/2011

Morphine Sulfate Immediate Release Tablets, 30 mg: The 30 mg Morphine Sulfate Immediate Release Tablet is a capsule shaped brown tablet with "30" on one side and an ETHEX on the reverse. Lots: 75093, 77855-57, 82297, 82521-22, 87239, 88925, and 90288-98 with expiration dates ranging from 8/2009 to 3/2011

Dextroamphetamine Sulfate Tablets, 10 mg: The 10 mg Dextroamphetamine Sulfate Tablet is a round, flat-face, bevel edge, orange mottled tablet debossed ETHEX and 312 on one side and double-scored on the other side. Lots: 73934, 75892, 77945, 81137, 86320 with expiration dates ranging from 6/2009 to 5/2011

All of the generic drugs involved in this latest recall were shipped prior to May 22, 2008. Consumers who have questions regarding the ETHEX generic drug recall should call their physicians or pharmacist. They may also contact ETHEX Customer Service at 1-800-748-1472. Consumers who experience any adverse reactions to these drugs should contact their physician and/or healthcare provider immediately.

Other ETHEX Generic Drug Recalls

ETHEX has had previous problems with over-sized medications. In June 2008, ETHEX recalled several lots of 60 mg and 30 mg morphine extended release tablets that may have been over-sized. The recall was issued after ETHEX received a report of one over-sized morphine tablet in one manufacturing lot. ETHEX characterized that recall as a precaution, and said that no additional over-sized tablets had been identified in the affected lots.

Then in October 2008, ETHEX recalled three lots of potentially over-sized Dextroamphetamine Sulfate 5 mg tablets. ETHEX issued the recall after it discovered and removed a small number of over-sized tablets in lots the company had not yet distributed. However, because there are multiple companies in the U.S. producing and marketing generic versions of Dextroamphetamine Sulfate 5 mg tablets, patients and caregivers were urged to check their prescriptions to determine the source of their tablets.

Legal Help for victims of Defective ETHEX Generic Drugs

If you or a loved one have been injured as a result of an over-sized ETHEX generic drug, you have valuable legal rights. Please fill out our online form, or call 1-800 YOURLAWYER (1-800-968-7529) to discuss your case with an experienced ETHEX generic drug recall lawyer.



 

KV Pleads Guilty, Agrees to Close ETHEX Generic Drug Plant

Feb 26, 2010 | Parker Waichman LLP
We have long been writing about a series of problems with K-V Pharmaceutical Company. In December, K-V Pharmaceutical said that the U.S. Food and Drug Administration (FDA) accepted its work plan to address the issues. Now, KV Pharmaceutical said it will be closing down its ETHEX generic drug unit, wrote The Associated Press (AP). The drug maker will also plead guilty to criminal charges that allege ETHEX neglected to appropriately advise regulators about significant manufacturing problems...

FDA Takes Action Against KV Pharmaceuticals

Mar 3, 2009 | Parker Waichman LLP
The U.S. Food and Drug Administration (FDA) just announced that a Consent Decree of permanent injunction was filed yesterday enjoining KV Pharmaceutical Company, its subsidiaries ETHEX Corporation and Ther-Rx Corporation, and its principal officers, from making and distributing adulterated and unapproved drugs.This is the most recent in an extensive series of incidents regarding KV Pharmaceuticals and its subsidiaries.  Early last month, ETHEX expanded a prior generic drug recall. ...

ETHEX Generic Drug Recall Expanded

Feb 5, 2009 | Parker Waichman LLP
ETHEX Corp. has expanded an earlier generic drug recall.  Like other ETHEX recalls from  the past several months, this expanded drug recalls was necessary because of manufacturing problems at KV Pharmaceuticals, the parent company of ETHEX.The expanded recall includes: Morphine Sulfate Extended-Release Tablets 15mg, 30mg & 60mg (All Strengths) Morphine Sulfate Immediate-Release Tablets 15mg & 30 mg (All Strengths) Dextroamphetamine Sulfate Tablets 5mg & 10mg (All...

ETHEX Recalls Infant Vitamins, Iron Supplements

Feb 4, 2009 | Parker Waichman LLP
ETHEX Corp. has issued another big drug recall.  This time ETHEX, a unit of KV Pharmaceuticals, is recalling several varieties of prescription infant vitamins  and prescription iron supplement products that may have been manufactured under conditions that did not sufficiently comply with the Food & Drug Administration's (FDA) current Good Manufacturing Practice (cGMP).Last month, KV Pharmaceuticals suspended manufacturing and shipping of all of its products, including those made...

ETHEX Issues Massive Recall of Generic Drugs

Jan 29, 2009 | Parker Waichman LLP
ETHEX Corp.  is recalling scores of generic drugs that might be defective. The recall is part of a larger action taken by KV Pharmaceuticals - the parent of ETHEX Corp. - which we reported on earlier this week. According to an ETHEX press release, the massive  recall is necessary because the medications  may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practices.  Some of the medications have had specific lots...

More Ethex News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo